陶通过乙化NLRP3诱导炎症酶激活和微化
Lun Zhang1,2, Yongkang Gai3, Yushuang Liu4
1Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry of China/Hubei Province for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Clinical and translational medicine
|March 15, 2024
概括
这项研究表明,tau蛋白直接乙化NLRP3 (含有3的核酸结合性寡合化域类受体皮林域),导致阿尔茨海默病 (AD) 和tau病变中的神经炎症. 阻止这种相互作用可以缓解认知障碍和微质激活.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 阿尔茨海默氏症 (AD) 和陶病症的特征是高酸化的陶蛋白聚合物和相关的神经炎症.
- 病理在这些神经退行性疾病中启动或调解微质激活的确切作用尚不清楚.
研究的目的:
- 调查tau病理和微质激活之间的因果关系.
- 阐明Tau影响神经炎症的分子机制,特别是涉及NLRP3炎症体.
主要方法:
- 在细胞模型,转基因小鼠和AD患者中评估了NLRP3 (含有3) 乙化和炎症酶激活的核酸结合寡合化域类受体皮林域).
- 利用生物化学分析,质谱和分子对接来确认Tau在NLRP3.3上的乙转移酶活性.
- 建立了一种Tau过度表达的小鼠模型来评估认知功能和微质激活,并测试了一种Tau-NLRP3相互作用阻断.
主要成果:
- 在多种类型的陶病症和阿兹海默症患者中观察到NLRP3乙化和炎症酶激活的升高.
- 酸化的变体显著促进了NLRP3乙化和炎症酶激活,直接在特定部位乙化NLRP3.
- 在小鼠中的过度表达导致认知能力下降和微质激活,这种情况通过阻断-NLRP3相互作用的来改善.
结论:
- 陶蛋白通过乙化NLRP3直接调节微质激活,这代表了AD和陶病的新机制.
- 针对Tau-NLRP3相互作用提供了早期干预和个性化治疗这些神经退行性疾病的潜在治疗策略.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:26Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...